TriArm is a clinical-stage cell therapy company leveraging its global presence and core non-viral platform to democratize curative CAR-T therapy for patients worldwide. Stay tuned as we execute on our mission to deliver better, safer, and more accessible CAR-T products to patients currently marginalized by manufacturability constraints and prohibitive cost tied to conventional CAR-T programs.